Norman Wolmark

1975–2026 年に発表

別表記
NORMAN WOLMARK
255
論文数
114,466
被引用数
141
h 指数
248
i10 指数

被引用数

Norman Wolmark の年別被引用数1974 年: 被引用 3 件1975 年: 被引用 3 件1976 年: 被引用 7 件1977 年: 被引用 12 件1978 年: 被引用 11 件1979 年: 被引用 12 件1980 年: 被引用 3 件1981 年: 被引用 5 件1982 年: 被引用 10 件1983 年: 被引用 19 件1984 年: 被引用 9 件1985 年: 被引用 34 件1986 年: 被引用 41 件1987 年: 被引用 37 件1988 年: 被引用 40 件1989 年: 被引用 86 件1990 年: 被引用 66 件1991 年: 被引用 101 件1992 年: 被引用 102 件1993 年: 被引用 84 件1994 年: 被引用 123 件1995 年: 被引用 109 件1996 年: 被引用 116 件1997 年: 被引用 132 件1998 年: 被引用 212 件1999 年: 被引用 320 件2000 年: 被引用 365 件2001 年: 被引用 541 件2002 年: 被引用 436 件2003 年: 被引用 533 件2004 年: 被引用 558 件2005 年: 被引用 712 件2006 年: 被引用 688 件2007 年: 被引用 774 件2008 年: 被引用 780 件2009 年: 被引用 801 件2010 年: 被引用 880 件2011 年: 被引用 819 件2012 年: 被引用 731 件2013 年: 被引用 798 件2014 年: 被引用 683 件2015 年: 被引用 750 件2016 年: 被引用 624 件2017 年: 被引用 585 件2018 年: 被引用 542 件2019 年: 被引用 2,083 件2020 年: 被引用 2,218 件2021 年: 被引用 2,003 件2022 年: 被引用 1,709 件2023 年: 被引用 1,253 件2024 年: 被引用 2,035 件2025 年: 被引用 899 件2026 年: 被引用 33 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 8,228 件、この内訳の 30.6%中国: 引用元論文 1,911 件、この内訳の 7.1%イギリス: 引用元論文 1,834 件、この内訳の 6.8%イタリア: 引用元論文 1,576 件、この内訳の 5.9%ドイツ: 引用元論文 1,193 件、この内訳の 4.4%カナダ: 引用元論文 1,191 件、この内訳の 4.4%フランス: 引用元論文 1,057 件、この内訳の 3.9%オランダ: 引用元論文 851 件、この内訳の 3.2%スペイン: 引用元論文 749 件、この内訳の 2.8%スイス: 引用元論文 679 件、この内訳の 2.5%オーストラリア: 引用元論文 663 件、この内訳の 2.5%日本: 引用元論文 643 件、この内訳の 2.4%
0%30.6%その他 23.5%

分野

  • Medicine50.3%
  • Biochemistry, Genetics and Molecular Biology43%
  • Computer Science1.5%
  • Immunology and Microbiology1.1%
  • Engineering0.8%
  • Materials Science0.6%
  • その他2.7%

トピック

  • Breast Cancer Treatment Studies13.5%
  • Breast Lesions and Carcinomas5.4%
  • HER2/EGFR in Cancer Research5.4%
  • Breast Implant and Reconstruction3.3%
  • Colorectal Cancer Surgical Treatments2.5%
  • Estrogen and related hormone effects2.5%
  • その他67.4%

共著者

全論文

検索で開く
  1. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernd Gerber, Charles E. Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, W. Eiermann, Gϋnter von Minckwitz - The Lancet 2014 被引用: 4,710

  2. Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 2,618

  3. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 被引用: 1,665

  4. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2004 被引用: 6,358

  5. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 被引用: 5,353

  6. Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

    著者: , , , , , , , - New England Journal of Medicine 2002 被引用: 6,228

  7. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2018 被引用: 771

  8. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

    著者: , , , , , , , , , , , , , , - The Lancet Oncology 2010 被引用: 1,919

  9. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain - The Lancet Oncology 2022 被引用: 299

  10. NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2+

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 420

  11. Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Otto Metzger, Anita Jallitsch-Halper, Kadine Solomon, Céline Schurmans, K. P. Theall, Dongrui R. Lu, Kathleen Tenner, Christian Fesl, Angela DeMichele, Erica L. Mayer, on behalf of the PALLAS groups and investigators - Journal of Clinical Oncology 2021 被引用: 231

  12. openalex_id:w4226348827

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, R. Jakesz, Christian Fesl, Olivia Pagani, Richard D. Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy S. Albain, Stewart Anderson, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain 被引用: 223

  13. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles E. Geyer, M. Spielmann, Pinuccia Valagussa, Kathy S. Albain, Stewart Anderson, R. Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Bidwell Goetz, Pam Goodwin, Pat Halpin-Murphy, Daniel Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori J. Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Tanja Španić, Joseph A. Sparano, Guenther G. Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Timothy J. Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I. Pritchard ほか 1 名 - The Lancet Oncology 2021 被引用: 348

  14. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 1,803

  15. Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2022 被引用: 219

  16. Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2021 被引用: 188

  17. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2006 被引用: 2,577

  18. Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 172

  19. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

    著者: , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 1998 被引用: 5,508

  20. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2007 被引用: 1,078

  21. Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 998

  22. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2019 被引用: 475

  23. Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation

    著者: , , , , , - New England Journal of Medicine 2002 被引用: 1,386

  24. Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mairead MacKenzie, Maggie Wilcox, Cynthia Huang Bartlett, María Koehler, Mitch Dowsett, Judith M. Bliss, Samuel A. Jacobs - Journal of Clinical Oncology 2018 被引用: 235